Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing

Gut

Volumn 55, Issue 5, 2006, Pages 681-688

  Okada, Y ^a   Tsuzuki, Y ^a   Miyazaki, J ^a   Matsuzaki, K ^a   Hokari, R ^a   Komoto, S ^a   Kato, S ^a   Kawaguchi, A ^a   Nagao, S ^a   Itoh, K ^a   Watanabe, T ^b   Miura, S ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1.4 DIHYDROXY 2 NAPHTHOIC ACID; BETA7 INTEGRIN; DEXTRAN SULFATE; DRINKING WATER; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL FLORA; CECUM; CELL INFILTRATION; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG EFFECT; ENTEROBACTERIACEAE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LACTOBACILLUS; LYMPHOCYTE HOMING; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROPIONIBACTERIUM FREUDENREICHII; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SURVIVAL RATE;

ANIMALS; BACTERIAL PROTEINS; CELL ADHESION MOLECULES; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; FATTY ACIDS, VOLATILE; FECES; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA CHAINS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; NAPHTHOLS; PROPIONIBACTERIUM; RECEPTORS, LYMPHOCYTE HOMING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; SURVIVAL RATE;

EID: 33646254148     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.070490     Document Type: Article

References (45)

1. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92(12 suppl):5S-11S.
2. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
3. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
4. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180:2359-64.
5. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
6. Mourelle M, Salas A, Guarner F, et al. Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 1998;114:519-26.
7. Madsen KL, Doyle JS, Jewell LD, et al. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 1999;116:1107-14.
8. Teramoto F, Rokutan K, Kawakami Y, et al. Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease. J Gastroenterol 1996;31:33-9.
9. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol 1999;94:427-33.
10. Kanauchi O, Iwanaga T, Mitsuyama K. Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis. Digestion 2001;63(suppl 1):60-7.
11. Cummings JH, Macfarlane GT, Englyst HN. Prebiotic digestion and fermentation. Am J Clin Nutr 2001;73(2 suppl):415S-20.
12. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004;126:1620-33.
13. Andoh A, Fujiyama Y, Hata K, et al. Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol 1999;118:23-9.
14. Kanauchi O, Andoh A, Iwanaga T, et al. Germinated barley foodstuffs attenuate colonic mucosal damage and mucosal nuclear factor kappa B activity in a spontaneous colitis model. J Gastroenterol Hepatol 1999;14:1173-9.
15. Roller M, Rechkemmer G, Watzl B. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr 2004;134:153-6.
16. Nakamura S, Ohtani H, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab Invest 1993;69:77-85.
17. Watanabe C, Miura S, Hokari R, et al. Spatial heterogeneity of TNF-alpha-induced T cell migration to colonic mucosa is mediated by MAdCAM-1 and VCAM-1. Am J Physiol Gastrointest liver Physiol 2002;283:G1379-87.
18. Streeter PR, Berg, EL, Rouse BT, et al. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 1988;331:41-6.
19. Briskin MJ, McEvoy LM, Butcher EC. MAdCAM-1 has homology to immunoglobulin and mucin-like adhesion receptors and to IgA1. Nature 1993;363:461-4.
20. Briskin M, Winsor-Hines D, Shyjan A, et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
21. Iizuka T, Tanaka T, Suematsu M, et al. Stage-specific expression of mucosal addressin cell adhesion molecule-1 during embryogenesis in rats. J Immunol 2000;164:2463-71.
22. Kato S, Hokari R, Matsuzaki K, et al. Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1. J Pharmacol Exp Ther 2000;295:183-9.
23. Hokari R, Kato S, Motsuzaki K, et al. Involvement of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the pathogenesis of granulomatous colitis in rats. Clin Exp Immunol 2001;126:259-65.
24. Isawa K, Hojo K, Yoda N, et al. Isolation and identification of a new bifidogenic growth stimulator produced by Propionibacterium freudenreichii ET-3. Biosci Biotechnol Biochem 2002;66:679-81.
25. Bentley R, Meganathan R. Vitamin K biosynthesis in bacteria - precursors, intermediates, enzymes, and genes. J Nat Prod 1983;46:44-59.
26. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
27. Cooper HS, Murthy SN, Shah RS, et al. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
28. Mitsuoka T, Ohno K, Benno Y, et al. [The fecal flora of man. IV. Communication: Comparison of the newly developed method with the old conventional method for the analysis of intestinal flora (author's translation)], Zentralbl Bakteriol [Orig A] 1976;234:219-33.
29. Hoshi S, Sakata T, Mikuni K, et al. Galactosylsucrose and xylosylfructoside alter digestive tract size and concentrations of cecal organic acids in rats fed diets containing cholesterol and cholic acid. J Nutr 1994;124:52-60.
30. Berlin C, Berg EL, Briskin MJ, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185-95.
31. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 1999;45:856-63.
32. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut 1992;33:933-7.
33. Sikorski EE, Hallmann R, Berg EL, et al. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. J Immunol 1993;151:5239-50.
34. Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999;10:39-49.
35. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulphate sodium progresses into chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005;288:G1328-38.
36. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
37. Ito H, Takazoe M, Fukuda Y, et al. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004;126:989-96.
38. Hoentjen FZX, Tannock GW, Dieleman LA. The prebiotic combination inulin and oligofructose prevents colitis in HLA-B27 transgenic rats. Can J Gastroenterol. 2004;18: (suppl A)).
39. Keusch GT GS. Enteric microbial ecology and infection, part 1 bacteria. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus gastroenterology, vol 2, 5th Edn. Philadelphia: Saunders, 1995:1115-1130.
40. Mitsuoka T, Kaneuchi C. Ecology of the bifidobacteria. Am J Clin Nutr 1977;30:1799-810.
41. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection ror Crohn's disease. Am J Gastroenterol 2002;97:939-46.
42. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors. Br J Nutr 1987;58:95-103.
43. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 1982;83:424-9.
44. Bamba T, Kanauchi O, Andoh A, et al. A new prebiotic from germinated barley for nutraceufical treatment of ulcerative colitis. J Gastroenterol Hepatol 2002;17:818-24.
45. Kanauchi O, Serizawa I, Araki Y, et al. Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol 2003;38:134-41.